TRISS as a Predictor of Trauma Patient Outcomes
Launched by AL-NAHRAIN UNIVERSITY · Nov 28, 2024
Trial Information
Current as of September 08, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial, called TRISS as a Predictor of Trauma Patient Outcomes, is studying how well the Trauma and Injury Severity Score (TRISS) can predict the chances of survival and other important outcomes for patients who have experienced trauma. The study is taking place at Kadhimiya Educational Hospital in Iraq and aims to see if TRISS can help doctors understand how likely it is that a trauma patient will need intensive care, surgery, or have a longer hospital stay.
To participate in this study, patients must be at least 18 years old and have been admitted to the emergency department due to trauma. Importantly, the study will assess patients using the TRISS score within the first hour of their arrival to get timely information. Throughout their hospital stay, the medical team will monitor their recovery, including whether they survive, need intensive care, or require surgery. This trial is currently looking for participants and aims to provide valuable insights that could help improve care for trauma patients.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Trauma patients admitted to the emergency department of Al-Kadhimiya Teaching Hospital.
- • Patients with adequate documentation of physiological and anatomical data are required for TRISS calculation.
- • Trauma scoring (TRISS) completed within the first 6 hours of hospital arrival to ensure timely assessment.
- Exclusion Criteria:
- • Patients under 18 years, pregnant women, or those with conditions that alter standard trauma scoring or management.
- • Non-trauma cases (e.g., medical emergencies, terminal illnesses) to ensure focus on trauma-specific outcomes.
- • Patients with incomplete or missing data required for TRISS calculation.
- • Patients declared dead on arrival or those not treated in the trauma and emergency department.
- • Individuals refusing participation or withdrawing consent at any stage of the study.
- • Patients transferred to or from another facility or enrolled in other studies that might affect scoring accuracy or outcomes.
About Al Nahrain University
Al-Nahrain University is a leading academic institution dedicated to advancing medical research and education in Iraq. With a focus on innovative clinical trials, the university aims to enhance healthcare outcomes through rigorous scientific investigation and collaboration with local and international partners. Its commitment to ethical research practices and adherence to regulatory standards positions Al-Nahrain University as a pivotal contributor to the development of new therapeutic interventions and the overall improvement of public health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Baghdad, , Iraq
Patients applied
Trial Officials
Mohammed A. Hamdawi, Professor
Study Director
College Of Medicine - Nahrain University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported